New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

Half of patients with anxiety and depression have been successfully treated using deep-brain stimulation. More than a third ...

A new study reveals that the first 180 days following a depression diagnosis are the most critical for mortality risk, ...

A BRAIN ‘pacemaker’ has helped treat over a third of severely depressed or anxious patients by correcting ‘bad brain signals’ ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

A new study investigating neuroinflammation in the ventral tegmental area (VTA) of the brain, a small, midbrain dopaminergic ...

Postpartum depression descended on Kristina Leos like a heavy fog that separated her from everyone she loved. She could see ...

A new clinical trial shows that deep brain stimulation (DBS) improved symptoms in half of adults with treatment-resistant depression, with one-third reaching remission.

A recent study has identified a previously unreported risk factor for major depression. The lingering trauma of forced sex.

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

In the most comprehensive investigation of the ketogenic diet’s mental health effects yet, researchers pooled 50 studies ...